The explosion of Kalshi and Polymarket meant Oscar gambling and interest skyrocketed, but these weren’t the healthy ...
A global corporate archival organization founded in 1979 has created a niche using AI to help marketers and advertisers access historic information about their brands and companies. The platform can ...
March 3 (Reuters) - The U.S. Food and Drug Administration has warned Novo Nordisk (NOVOb.CO), opens new tab over a consumer ad for its blockbuster diabetes drug, Ozempic, saying the commercial makes ...
March 3 (Reuters) - The U.S. Food and Drug Administration has warned Novo Nordisk over a consumer ad for its blockbuster diabetes drug, Ozempic, saying the commercial makes false and misleading ...
A box of Ozempic and contents sit on a table in Dudley, North Tyneside, Britain, October 31, 2023. REUTERS/Lee Smith March 3 (Reuters) - The U.S. Food and Drug Administration has told Novo Nordisk ...
AT&T is updating a prior lawsuit against T-Mobile with new allegations of false advertising. AT&T accuses T-Mobile’s claims of big savings are deceiving. Furthermore, it adds that the claim about ...
Four varieties of Fairlife, an upscale milk brand owned by Coca Cola (courtesy of Fairlife) LOS ANGELES (CN) — Fairlife, an upscale milk brand owned by Coca-Cola, must face claims that its logo is ...
Officials in Fulton County, Georgia, accused the Justice Department of making “serious” omissions in the application the FBI filed to obtain a search warrant for 2020 election ballots last month. The ...
T-Mobile just got in trouble over misleading free in-flight Wi-Fi claims (Update: T-Mobile responds)
The National Advertising Division has recommended that T-Mobile discontinue or modify claims about its free in-flight Wi-Fi advertising. T-Mobile’s advertising suggests that Verizon customers incur a ...
The U.S. Food and Drug Administration said a television advertisement for Novo Nordisk's weight-loss pill is "false or misleading," according to a letter dated February 5. The health regulator said ...
FDA enforcement will focus on restricting GLP-1 APIs in mass-marketed, nonapproved compounded products to address unverifiable quality, safety, and efficacy under the FD&C Act. Appropriate compounding ...
To some, METR’s “time horizon plot” indicates that AI utopia—or apocalypse—is close at hand. The truth is more complicated. MIT Technology Review Explains: Let our writers untangle the complex, messy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results